2022-09-06 · Notice · 2022-19155
Issuance of Priority Review Voucher; Rare Pediatric Disease Product
Vosoritide
Open attributed record →Federal Register publication year
2022 FDA Federal Register peptide records
6 documents attributed to FDA and HHS and published in 2022, connected only through exact reviewed peptide-name matches.
2022-08-29 · Notice · 2022-18523
Notice of Approval of Product Under Voucher: Material Threat Medical Countermeasure Priority Review Voucher
Tirzepatide
Open attributed record →2022-08-03 · Notice · 2022-16502
Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
Setmelanotide
Open attributed record →2022-07-01 · Notice · 2022-14134
Determination of Regulatory Review Period for Purposes of Patent Extension; IMCIVREE
Setmelanotide
Open attributed record →2022-05-20 · Notice · 2022-10701
Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
Exenatide + Linaclotide
Open attributed record →2022-02-18 · Notice · 2022-03248
Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
Leuprolide
Open attributed record →